SCHEMBL22153264

SCHEMBL22153264

N#Cc1ccc(-n2c3ccccc3c3cccc(-n4c5ccccc5c5ccccc54)c32)cc1-c1ccc(-n2c3ccccc3c3cccc(C#N)c32)cc1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34
ESR2 Q92731 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PPARG P37231 1/20 0.31
CYP11B1 P15538 1/20 0.31
CYP11B2 P19099 1/20 0.31
HIF1A Q16665 1/20 0.31
IMPDH2 P12268 1/20 0.30
PARP1 P09874 1/20 0.30
TRPA1 O75762 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22152482 1.00 NR3C1 (0.34) NR3C1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL22378759 0.93 NR3C1 (0.36) NR3C1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL22154134 0.92 SMN1; SMN2 (0.36) NR3C1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL22154135 0.92 SMN1; SMN2 (0.36) NR3C1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL22152898 0.91 NR3C1 (0.32) NR3C1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL22152417 0.91 NR3C1 (0.32) NR3C1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL22153737 0.91 NR3C1 (0.32) NR3C1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL22153855 0.91 NR3C1 (0.32) NR3C1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL22152756 0.91 NR3C1 (0.34) NR3C1SMN1; SMN2ALDH1A1LMNAHPGD
SCHEMBL22152791 0.91 NR3C1 (0.34) NR3C1SMN1; SMN2ALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203625-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203625-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 NR3C1 1020/4885SMN1; SMN2 4714/4885ALDH1A1 1500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.